CS logo
small CS logo
Stony Brook University Cancer Center

Stony Brook, New York, United States
Oncologist in Stony Brook, New York
Lauterbur Dr, Stony Brook, NY 11794

About Stony Brook University Cancer Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Children's Oncology Group
26
Alliance for Clinical Trials in Oncology
14
Gynecologic Oncology Group
12
Pfizer
10
Stony Brook University
7
Radiation Therapy Oncology Group
5
ECOG-ACRIN Cancer Research Group
3
NSABP Foundation Inc
3
Seagen Inc.
3
Alison Stopeck
2
AlloVir
2
Total Rows: 36

Clinical Trials at Stony Brook University Cancer Center


During the past decade, Stony Brook University Cancer Center conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 34 clinical trials were completed, i.e. on average, 91.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 11 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22553399771155553355993333225522Started TrialsCompleted Trails201520162017201820192020202120220510
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
1993-12-01
Completed
216
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
1996-06-01
2012-03-01
Completed
221
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
1997-04-01
2012-04-01
Completed
428
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
1997-08-01
2011-01-01
Completed
483
Combination Chemotherapy in Treating Children With Neuroblastoma
1988-03-01
2011-01-01
Completed
573
Surgery in Treating Children With Neuroblastoma
1998-03-01
2006-03-01
Completed
968
Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
1999-06-01
2012-04-01
Completed
254
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150

Rows per page:

1–100 of 116

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Stony Brook University Cancer Center" #1 sponsor was "Children's Oncology Group" with 26 trials, followed by "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "Gynecologic Oncology Group" with 12 trials sponsored, "Pfizer" with 10 trials sponsored and "Stony Brook University" with 10 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 36 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Stony Brook University Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 27 trials.
Created with Highcharts 11.1.0Top Leading SponsorsChildren's Oncology Group: 26Children's Oncology Group: 26Alliance for ClinicalTrials in Oncology: 14Alliance for ClinicalTrials in Oncology: 14Gynecologic OncologyGroup: 12Gynecologic OncologyGroup: 12Pfizer: 10Pfizer: 10Stony Brook University: 7Stony Brook University: 7Radiation TherapyOncology Group: 5Radiation TherapyOncology Group: 5ECOG-ACRIN CancerResearch Group: 3ECOG-ACRIN CancerResearch Group: 3NSABP Foundation Inc: 3NSABP Foundation Inc: 3Seagen Inc.: 3Seagen Inc.: 3Alison Stopeck: 2Alison Stopeck: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 68National CancerInstitute (NCI): 68NRG Oncology: 4NRG Oncology: 4SWOG Cancer ResearchNetwork: 4SWOG Cancer ResearchNetwork: 4NCIC Clinical Trials Group: 3NCIC Clinical Trials Group: 3Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Eli Lilly and Company: 2Eli Lilly and Company: 2Ipsen: 2Ipsen: 2Merck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2UCB Pharma: 2UCB Pharma: 2American College ofSurgeons: 1American College ofSurgeons: 1

Clinical Trials Conditions at Stony Brook University Cancer Center


According to Clinical.Site data, the most researched conditions in "Stony Brook University Cancer Center" are "Leukemia" (12 trials), "Breast Cancer" (10 trials), "Lung Cancer" (10 trials), "Sarcoma" (8 trials) and "Lymphoma" (6 trials). Many other conditions were trialed in "Stony Brook University Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Stony Brook University Cancer Center


Most popular intervention types in "Stony Brook University Cancer Center" are "Drug" (89 trials), "Biological" (30 trials), "Radiation" (25 trials), "Procedure" (20 trials) and "Other" (12 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (16 trials), "filgrastim" (15 trials), "radiation therapy" (14 trials), "cytarabine" (12 trials) and "vincristine sulfate" (12 trials). Other intervention names were less common.

Clinical Trials Genders at Stony Brook University Cancer Center


The vast majority of trials in "Stony Brook University Cancer Center" are 89 trials for "All" genders, 24 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at Stony Brook University Cancer Center


Currently, there are NaN active trials in "Stony Brook University Cancer Center". undefined are not yet recruiting, 11 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 79 completed trials in Stony Brook University Cancer Center, 1 suspended trials, and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Stony Brook University Cancer Center, 4 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 52Phase 3: 52Phase 2: 48Phase 2: 48Not Applicable: 5Not Applicable: 5Phase 1: 4Phase 1: 4Early Phase 1: 2Early Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 79Completed: 79Active, not recruiting: 12Active, not recruiting: 12Recruiting: 11Recruiting: 11Terminated: 9Terminated: 9Approved for marketing: 1Approved for marketing: 1Available: 1Available: 1Suspended: 1Suspended: 1Unknown status: 1Unknown status: 1Withdrawn: 1Withdrawn: 1